Date: Nov 29, 2017
The advanced Federal Register notice also includes a list of the following six questions for commenters to consider as they prepare their comments or statements:
The public hearing will be held on Friday, January 26, 2018. Persons seeking to attend or to present at the public hearing must register by Tuesday, January 2, 2018. Electronic or written comments will be accepted after the public hearing until Thursday, February 15, 2018. The advanced Federal Register notice is attached and available here.
FDA also announced that the agency is forming a Nicotine Steering Committee to help develop and implement nicotine policy and regulation to address the public health crisis of addiction to tobacco products. The committee, which will include senior leadership from the Center for Tobacco Products, Center for Drug Evaluation and Research, and Office of the Commissioner, will focus on nicotine replacement therapies (NRTs), which are designed to help people quit smoking. The committee will examine the evolving science behind the agency's evaluation of these NRTs, including the types of safety and efficacy studies FDA requires and how these products are used and labeled. The Committee's first action will be to hold the public hearing described above. Whether and how, if at all, the Committee will consider the impact of recreational nicotine-containing products, such as e-vapor and heat-not-burn products, on promoting tobacco harm reduction among adult cigarette smokers, for example, remains unclear.
Learn more about this and other issues relevant to the nicotine, e-vapor and deemed tobacco product industries at our upcoming E-Vapor and Tobacco Law Symposium in Irvine, California on February 6-7, 2018. For more information and to register, please click here.